THE MEDICAL CENTER
1. Target Overview & Investment Thesis
THE MEDICAL CENTER is a 310-bed suburban community hospital in WARREN, KY with $451.0M in net patient revenue and a 4.2% operating margin. The hospital serves a payer mix of 25.0% Medicare, 2.3% Medicaid, and 72.6% commercial.
Thesis: Undervalued. Our ML models identify $33.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.2% to 11.5% (+736bps).
| Net Revenue HCRIS | $451.0M |
| Current EBITDA COMPUTED | $18.8M |
| Operating Margin COMPUTED | 4.2% |
| Occupancy HCRIS | 73.0% |
| Revenue / Bed COMPUTED | $1.5M |
| Net-to-Gross HCRIS | 30.7% |
| Distress Probability ML | 42.7% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 4.2% places it above the state median. Among 18 size-comparable peers (155-620 beds), the median margin is -4.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (155-620), prioritizing same-state peers. 18 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| THE MEDICAL CENTER (Target) | KY | 310 | $451.0M | 4.2% |
| ST ELIZABETH HEALTHCARE | KY | 448 | $1.07B | -13.2% |
| UNIVERSITY OF LOUISVILLE HOSPI | KY | 333 | $806.1M | -6.9% |
| BAPTIST HEALTH LEXINGTON | KY | 434 | $760.6M | 2.8% |
| OWENSBORO HEALTH REGIONAL HOSP | KY | 302 | $678.6M | 11.1% |
| BAPTIST HEALTH LOUISVILLE | KY | 454 | $677.1M | -7.2% |
| PIKEVILLE MEDICAL CENTER | KY | 328 | $555.1M | -16.6% |
| KINGS DAUGHTERS MEDICAL CENTER | KY | 367 | $542.4M | -20.5% |
| BAPTIST HEALTH HARDIN | KY | 259 | $459.5M | -1.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $33.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $9.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $9.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $8.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $5.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $289K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $18.8M |
| + RCM Uplift | +$33.2M |
| Pro Forma EBITDA | $52.0M |
| Current Margin | 4.2% |
| Pro Forma Margin | 11.5% |
| WC Released (1x) | $17.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $29.0M | $456.1M | 15.75x | 73.6% |
| Base (11x exit) | 10.0x | 11.0x | $29.0M | $511.1M | 17.65x | 77.6% |
| Bull Case | 9.0x | 11.0x | $26.1M | $630.0M | 24.18x | 89.1% |
| Bull (12x exit) | 9.0x | 12.0x | $26.1M | $695.0M | 26.67x | 92.8% |
| Bear Case | 11.0x | 10.0x | $31.8M | $280.7M | 8.81x | 54.5% |
| Bear (11x exit) | 11.0x | 11.0x | $31.8M | $319.1M | 10.02x | 58.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 18 hospitals with 155-620 beds
- Same-state prioritization (n=19)
- Comp margins: P25=-15.9% / P50=-4.2% / P75=2.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.